Processa Pharmaceuticals, Inc. Total Revenue

• Processa Pharmaceuticals, Inc. showed a decrease of -95.6% in Total Revenue from 2015 to 2016.
• This data is from Processa Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on September 25, 2017.
• XBRL data for this metric is available from 2012 to 2016 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2012: $49.1 thousand | Q1 2013: $19.2 thousand | Q2 2013: $97.3 thousand | Q3 2013: $125.9 thousand | Q1 2014: $20.4 thousand | Q2 2014: $112.8 thousand | Q3 2014: $52.6 thousand | Q1 2015: $37.8 thousand | Q2 2015: $20.0 thousand | Q3 2015: $58.2 thousand | Q1 2016: $5.0 thousand.
• Over the full 5 years of available data (2012 to 2016), Processa Pharmaceuticals, Inc.'s Total Revenue has declined by 97.4%.
• Historical annual values: Fiscal year 2016: $5.0 thousand | Fiscal year 2015: $113.4 thousand | Fiscal year 2014: $107.2 thousand | Fiscal year 2013: $312.5 thousand | Fiscal year 2012: $192.1 thousand.
• Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: August 5, 2026